China-based New Horizon Health, which produces home cancer test kits, has raised $66 million in a Series C round of funding led by VMS Group, a Hong Kong-based investment firm.
The company’s existing investors Legend Capital and Softbank China also re-upped. New Horizon raised its angel round of RMB5 million ($725,400) from Linhui Fund and Haibang Capital in 2013, while three...
India’s Innoven Capital, a joint venture between UOB and Temasek Holdings-owned Seviora Holdings, has fractionalised a USD 50m venture debt fund using blockchain and smart contracts.
OneVentures and UniQuest have led a AUD 34m (USD 23m) funding round for Vaxxas, an Australia-based biotechnology company running clinical programmes that include a needle-free COVID-19 vaccine candidate.
Temasek Holdings, A91 Partners, and Kae Capital have invested USD 135m in Indian omnichannel wellness products retailer HealthKart.